Electrohydrodynamic comminution: A novel technique for the aerosolisation of plasmid DNA

被引:34
作者
Davies, LA
Hannavy, K
Davies, N
Pirrie, A
Coffee, RA
Hyde, SC
Gill, DR [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, GeneMed Res Grp, Oxford OX3 9DU, England
[2] Electrosols Ltd, Magdalen Ctr, Oxford OX4 4GA, England
基金
英国医学研究理事会;
关键词
aerosolisation; electrohydrodynamic; gene transfer; naked DNA;
D O I
10.1007/s11095-005-5268-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Naked plasmid DNA (pDNA) is a potential gene transfer agent for lung gene therapies but cannot be aerosolised without degradation using conventional nebulisation devices. This study investigated the viability of an alternative nebulisation technique, electrohydrodynamic (EHD) comminution for the aerosol delivery of naked DNA in vivo. Methods. Naked pDNA was aerosolised using jet and ultrasonic nebulisers, and by EHD comminution. Degradation associated with the aerosolisation process was investigated using gel electrophoresis and by transfection studies in cell culture. Optimised formulations for EHD aerosolisation of pDNA were developed and in vivo deposition and reporter gene expression were investigated in mice. Results. Unlike conventional nebulisation devices, EHD comminution of plasmids up to 15 kb in size resulted in no detectable pDNA degradation. EHD formulations containing up to 1 mg/ml pDNA were developed and shown to produce monodisperse aerosols suitable for targeted lung delivery in humans. Aerosolisation studies in vivo demonstrated detectable levels of pDNA deposition and measurable luciferase reporter gene expression in the lungs of exposed mice. Conclusions. This study demonstrates for the first time that respirable aerosols of naked pDNA can be generated without plasmid degradation and that EHD comminution is an appropriate technique for the aerosolisation of delicate gene transfer agents.
引用
收藏
页码:1294 / 1304
页数:11
相关论文
共 44 条
[1]   Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis:: a double-blind placebo-controlled trial [J].
Alton, EWFW ;
Stern, M ;
Farley, R ;
Jaffe, A ;
Chadwick, SL ;
Phillips, J ;
Davies, J ;
Smith, SN ;
Browning, J ;
Davies, MG ;
Hodson, ME ;
Durham, SR ;
Li, D ;
Jeffery, PK ;
Scallan, M ;
Balfour, R ;
Eastman, SJ ;
Cheng, SH ;
Smith, AE ;
Meeker, D ;
Geddes, DM .
LANCET, 1999, 353 (9157) :947-954
[2]  
ALTON EWFW, 1995, GENE THER, V2, P88
[3]  
[Anonymous], 1988, ANN OCCUP HYG, DOI [DOI 10.1093/ANNHYG/32.INHALED_, DOI 10.1093/ANNHYG/32.INHALED_PARTICLES_VI.53]
[4]   Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial [J].
Bellon, G ;
MichelCalemard, L ;
Thouvenot, D ;
Jagneaux, V ;
Poitevin, F ;
Malcus, C ;
Accart, N ;
Layani, MP ;
Aymard, M ;
Bernon, H ;
Bienvenu, J ;
Courtney, M ;
Doring, G ;
Gilly, B ;
Gilly, R ;
Lamy, D ;
Levrey, H ;
Morel, Y ;
Paulin, C ;
Perraud, F ;
Rodillon, L ;
Sene, C ;
So, S ;
TouraineMoulin, F ;
Schatz, C ;
Pavirani, A .
HUMAN GENE THERAPY, 1997, 8 (01) :15-25
[5]  
BOYD AC, 1999, PED PLUM S, V19, P237
[6]  
Chen JB, 1996, J OBJECT-ORIENT PROG, V8, P26
[7]  
CIPOLLA DC, 1994, STP PHARMA SCI, V4, P50
[8]   MODELING THE DEPOSITION OF INHALED POWDERED DRUG AEROSOLS [J].
CLARK, AR ;
EGAN, M .
JOURNAL OF AEROSOL SCIENCE, 1994, 25 (01) :175-186
[9]   ELECTROSTATIC SPRAYING OF LIQUIDS IN CONE-JET MODE [J].
CLOUPEAU, M ;
PRUNETFOCH, B .
JOURNAL OF ELECTROSTATICS, 1989, 22 (02) :135-159
[10]  
Coates AL, 1998, PEDIATR PULM, V26, P412, DOI 10.1002/(SICI)1099-0496(199812)26:6<412::AID-PPUL6>3.3.CO